Close

Teva Pharma (TEVA), Checkpoint Therapeutics (FBIO) Announce License Agreement for Oral PARP Inhibitor

January 7, 2016 10:59 AM EST Send to a Friend
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech (NASDAQ: FBIO) Company, announced today a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login